US Stock MarketDetailed Quotes
CRVO CervoMed
- 9.155
- +1.175+14.72%
Close Nov 27 16:00 ET
- 9.500
- +0.345+3.77%
Post 20:01 ET
75.56MMarket Cap-6326P/E (TTM)
10.290High8.260Low586.64KVolume8.540Open7.980Pre Close5.55MTurnover14.37%Turnover RatioLossP/E (Static)8.25MShares26.37952wk High1.66P/B37.37MFloat Cap5.85052wk Low--Dividend TTM4.08MShs Float3375000000.000Historical High--Div YieldTTM25.44%Amplitude4.140Historical Low9.452Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
CervoMed Stock Forum
CervoMed Announces Orphan Drug Designation Granted to Neflamapimod by U.S. Food and Drug Administration for the Treatment of Frontotemporal Dementia
CervoMed (NASDAQ: CRVO) announced that its oral drug neflamapimod received Orphan Drug Designation from the FDA for treating frontotemporal dementia (FTD).
The designation applies to therapies for rare diseases affecting fewer than 200,000 people in the US and provides benefits including tax credits, development assistance,...
CervoMed Announces Orphan Drug Designation Granted to Neflamapimod by U.S. Food and Drug Administration for the Treatment of Frontotemporal Dementia
why everything is moving so slow today??
😂 😆
No comment yet